Covered recipient · General Payments record
LORIN MICHAEL GRAEF
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,934.33
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $812.92 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $346.01 | 15 |
| EISAI INC. | $120.65 | 1 |
| Lilly USA, LLC | $86.34 | 3 |
| ARGENX US, INC. | $76.80 | 3 |
| Merz Pharmaceuticals, LLC | $58.53 | 2 |
| Alexion Pharmaceuticals, Inc. | $34.11 | 1 |
| MDD US Operations, LLC | $31.13 | 1 |
| Otsuka America Pharmaceutical, Inc. | $24.43 | 1 |
| REVANCE THERAPEUTICS, INC. | $18.98 | 1 |
| PFIZER INC. | $15.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.79 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827410 | CMS |
| ABBVIE INC. | $22.12 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827412 | CMS |
| ABBVIE INC. | $23.62 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827414 | CMS |
| ABBVIE INC. | $28.78 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827416 | CMS |
| ABBVIE INC. | $28.78 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827418 | CMS |
| ABBVIE INC. | $20.64 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827420 | CMS |
| ABBVIE INC. | $24.61 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827422 | CMS |
| ABBVIE INC. | $17.18 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827424 | CMS |
| ABBVIE INC. | $23.80 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827426 | CMS |
| ABBVIE INC. | $27.14 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827428 | CMS |
| ABBVIE INC. | $2.50 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827430 | CMS |
| ABBVIE INC. | $23.06 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827432 | CMS |
| ABBVIE INC. | $29.59 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827434 | CMS |
| ABBVIE INC. | $26.53 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827436 | CMS |
| ABBVIE INC. | $23.87 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827438 | CMS |
| Alexion Pharmaceuticals, Inc. | $34.11 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094017582 | CMS |
| ARGENX US, INC. | $28.00 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142102538 | CMS |
| ARGENX US, INC. | $24.16 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142103478 | CMS |
| ARGENX US, INC. | $24.64 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142104803 | CMS |
| Eisai Inc. | $120.65 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110761111 | CMS |
| Lilly USA, LLC | $25.66 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135132579 | CMS |
| Lilly USA, LLC | $30.13 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135147776 | CMS |
| Lilly USA, LLC | $30.55 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135132581 | CMS |
| MDD US Operations, LLC | $31.13 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147768201 | CMS |
| Merz Pharmaceuticals, LLC | $28.11 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137951704 | CMS |
| Merz Pharmaceuticals, LLC | $30.42 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137951702 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.43 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118900362 | CMS |
| PFIZER INC. | $15.94 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131458098 | CMS |
| REVANCE THERAPEUTICS, INC. | $18.98 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147919134 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.